Ottobock, DE000BCK2223

Ottobock faces Russia lawsuit. Ottobock stock sits 0.75 percent below its Xetra close

Published on 10/19/2026 at 09:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Core revenue rose 11.70 percent in fiscal year 2025. Ottobock stock costs EUR 53.20 on October 19, 2026, 0.75 percent below the Xetra close.

Russia disclosure and operating progress

  • A lawsuit over Ottobock's Russia disclosures was reported on October 9, 2026, involving 10 percent of revenue.
  • Core revenue increased 11.70 percent to EUR 0.2 billion in fiscal year 2025.
  • Ottobock stock trades at EUR 53.20 at 9:03 a.m. CEST at Lang & Schwarz on October 19, 2026, 0.75 percent below the Xetra close of October 16, 2026.
Ottobock, DE000BCK2223, Illustration mit AI erstellt.

Ottobock stock (ISIN DE000BCK2223) was trading at EUR 53.20 at Lang & Schwarz on October 19, 2026, at 9:03 a.m. CEST, 0.75 percent below the Xetra close of October 16, 2026. The company faces a lawsuit over its Russia disclosures, while a report dated October 9, 2026, said Russia still accounts for 10 percent of revenue.

manager magazin reported that the Deutsche Schutzgemeinschaft für Wertpapierbesitz wants a court to examine whether investors received a complete picture of the Russia business before the October 2025 listing. The report put the disputed revenue exposure at 10 percent.

The company has rejected the allegations. On September 25, 2026, NDR reported that Ottobock said its Russian activities served the civilian market and that the company stood by the integrity of its capital-market information. The court was still examining whether the case would be admitted.

What does the growth mean for margins?

Operating figures provide a second reference point. Ottobock's investor-relations page reports core revenue of EUR 0.2 billion in fiscal year 2025, up 11.70 percent, while adjusted EBITDA reached EUR 52.51 million, an increase of 29.50 percent. Adjusted group profit rose 83.20 percent to EUR 22.40 million in the same period.

The margin trend was also positive in the company's fiscal year 2025 figures. Core-business adjusted EBITDA was reported at 3.289 percent, up 3.60 percentage points, giving investors an operating metric to compare with the legal and disclosure risks.

When are the next company dates?

EQS News lists the Q3 2026 quarterly statement and webcast for November 12, 2026. The company is also scheduled for the BNP Paribas MidCap CEO Conference on November 16, 2026.

Stock stays below the prior close

At EUR 53.20, the Lang & Schwarz indication is EUR 0.40 below the EUR 53.60 Xetra close from October 16, 2026. The next dated corporate event is the Q3 statement on November 12, 2026.

The further course of trading is shown by the continuously updated real-time quote of Ottobock stock.

Ottobock stock key data

  • Company: Ottobock SE & Co. KGaA
  • ISIN: DE000BCK2223
  • WKN: BCK222
  • Ticker: OBCK
  • Primary exchange: Xetra
  • Price Lang & Schwarz (as of October 19, 2026, 9:03 a.m. CEST): EUR 53.20
  • Change versus Xetra close: minus 0.75 percent
  • Xetra close (October 16, 2026): EUR 53.60
  • Sector / Industry: Health care / medical technology

Market context: Market report DAX.

More news and analyses on Ottobock stock

Disclaimer...
en | DE000BCK2223 | OTTOBOCK | boerse | 70359018 | bgmi